Shares of Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) have been given an average recommendation of “Buy” by the six brokerages that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective among […]
Sema4 (NASDAQ:SMFR – Get Rating) and Pear Therapeutics (NASDAQ:PEAR – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability. Profitability This table compares Sema4 and Pear Therapeutics’ net margins, […]
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.